{"title":"Albumin-Coated Copper Oxide Nanoparticles for Radiosensitization of Human Glioblastoma Cells Under Clinically Relevant X-Ray Irradiation.","authors":"Chanyatip Suwannasing, Nittiya Suwannasom, Pattawat Iamcharoen, Rachan Dokkham, Panupong Maun, Pitchayuth Srisai, Hans Bäumler, Ausanai Prapan","doi":"10.3390/nano15171376","DOIUrl":null,"url":null,"abstract":"<p><p>Glioblastoma (GBM) is the most aggressive and treatment-resistant primary brain tumor in adults. Despite current multimodal therapies, including surgery, radiation, and temozolomide chemotherapy, patient outcomes remain poor. Enhancing tumor radiosensitivity through biocompatible nanomaterials could provide a promising integrative strategy for improving therapeutic effectiveness. This study aims to evaluate the potential of bovine serum albumin-coated copper oxide nanoparticles (BSA@CuO-NPs) to enhance radiosensitivity in U87-MG cells under clinically relevant X-ray irradiation. In brief, BSA@CuO-NPs were synthesized via carbodiimide crosslinking and characterized by DLS, SEM, and zeta potential analysis. U87-MG cells were treated with BSA@CuO-NPs alone or in combination with X-ray irradiation (2 Gy). Cytotoxicity was assessed using the MTT assay, while radiosensitization was evaluated through clonogenic survival analysis. Apoptosis induction and DNA damage were analyzed via Annexin V staining and γ-H2AX immunofluorescence, respectively. The results revealed that BSA@CuO-NPs showed good colloidal stability and biocompatibility compared with uncoated CuO-NPs. When combined with irradiation, BSA@CuO-NPs significantly decreased clonogenic survival (<i>p</i> < 0.05) and increased apoptotic cell death compared to irradiation alone. Immunofluorescence demonstrated increased γ-H2AX focus formation, indicating higher DNA double-strand breaks in the combination group. In conclusion, BSA@CuO-NPs enhance the effects of ionizing radiation by increasing DNA damage and apoptosis in U87-MG cells, indicating their potential as combined radiosensitizers. These results support further research into albumin-coated metal oxide nanoparticles as adjuncts to standard radiotherapy for the management of GBM. One challenge in this context is the effective delivery of nanoparticles to GBM. However, the stability of BSA@CuO-NPs in physiological solutions could help overcome this obstacle.</p>","PeriodicalId":18966,"journal":{"name":"Nanomaterials","volume":"15 17","pages":""},"PeriodicalIF":4.3000,"publicationDate":"2025-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12430620/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nanomaterials","FirstCategoryId":"88","ListUrlMain":"https://doi.org/10.3390/nano15171376","RegionNum":3,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0
Abstract
Glioblastoma (GBM) is the most aggressive and treatment-resistant primary brain tumor in adults. Despite current multimodal therapies, including surgery, radiation, and temozolomide chemotherapy, patient outcomes remain poor. Enhancing tumor radiosensitivity through biocompatible nanomaterials could provide a promising integrative strategy for improving therapeutic effectiveness. This study aims to evaluate the potential of bovine serum albumin-coated copper oxide nanoparticles (BSA@CuO-NPs) to enhance radiosensitivity in U87-MG cells under clinically relevant X-ray irradiation. In brief, BSA@CuO-NPs were synthesized via carbodiimide crosslinking and characterized by DLS, SEM, and zeta potential analysis. U87-MG cells were treated with BSA@CuO-NPs alone or in combination with X-ray irradiation (2 Gy). Cytotoxicity was assessed using the MTT assay, while radiosensitization was evaluated through clonogenic survival analysis. Apoptosis induction and DNA damage were analyzed via Annexin V staining and γ-H2AX immunofluorescence, respectively. The results revealed that BSA@CuO-NPs showed good colloidal stability and biocompatibility compared with uncoated CuO-NPs. When combined with irradiation, BSA@CuO-NPs significantly decreased clonogenic survival (p < 0.05) and increased apoptotic cell death compared to irradiation alone. Immunofluorescence demonstrated increased γ-H2AX focus formation, indicating higher DNA double-strand breaks in the combination group. In conclusion, BSA@CuO-NPs enhance the effects of ionizing radiation by increasing DNA damage and apoptosis in U87-MG cells, indicating their potential as combined radiosensitizers. These results support further research into albumin-coated metal oxide nanoparticles as adjuncts to standard radiotherapy for the management of GBM. One challenge in this context is the effective delivery of nanoparticles to GBM. However, the stability of BSA@CuO-NPs in physiological solutions could help overcome this obstacle.
期刊介绍:
Nanomaterials (ISSN 2076-4991) is an international and interdisciplinary scholarly open access journal. It publishes reviews, regular research papers, communications, and short notes that are relevant to any field of study that involves nanomaterials, with respect to their science and application. Thus, theoretical and experimental articles will be accepted, along with articles that deal with the synthesis and use of nanomaterials. Articles that synthesize information from multiple fields, and which place discoveries within a broader context, will be preferred. There is no restriction on the length of the papers. Our aim is to encourage scientists to publish their experimental and theoretical research in as much detail as possible. Full experimental or methodical details, or both, must be provided for research articles. Computed data or files regarding the full details of the experimental procedure, if unable to be published in a normal way, can be deposited as supplementary material. Nanomaterials is dedicated to a high scientific standard. All manuscripts undergo a rigorous reviewing process and decisions are based on the recommendations of independent reviewers.